Ibrutinib is a small molecule inhibitor of Bruton’s tyrosine kinase (BTK).
API supplied by Lonaze since 2013 and the FDF manufactured by Catalent.
| Product Name |
Ibrutinib |
| CAS Number |
936563-96-1 |
| Therapeutic Class |
Antineoplastic agents, Tyrosine kinase inhibitors |
| Dosage Form |
Oral Capsules, Tablets |
| Availability |
Development Completed |
| Regulatory Status |
USDMF |